BR112018071493A2 - usos de ácido linoleico (la) e ácido alfa-linolênico (ala) na fabricação de uma composição nutricional, composição nutricional, método para prevenir declínio no funcionamento cognitivo induzido e método para prevenir redução na neurogênese induzida por estresse precoce - Google Patents
usos de ácido linoleico (la) e ácido alfa-linolênico (ala) na fabricação de uma composição nutricional, composição nutricional, método para prevenir declínio no funcionamento cognitivo induzido e método para prevenir redução na neurogênese induzida por estresse precoceInfo
- Publication number
- BR112018071493A2 BR112018071493A2 BR112018071493-3A BR112018071493A BR112018071493A2 BR 112018071493 A2 BR112018071493 A2 BR 112018071493A2 BR 112018071493 A BR112018071493 A BR 112018071493A BR 112018071493 A2 BR112018071493 A2 BR 112018071493A2
- Authority
- BR
- Brazil
- Prior art keywords
- nutritional composition
- preventing
- ala
- induced
- manufacture
- Prior art date
Links
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 235000016709 nutrition Nutrition 0.000 title abstract 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 title abstract 2
- 230000001149 cognitive effect Effects 0.000 title abstract 2
- 230000007423 decrease Effects 0.000 title abstract 2
- 235000020778 linoleic acid Nutrition 0.000 title abstract 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 title abstract 2
- 230000004766 neurogenesis Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000009286 beneficial effect Effects 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hospice & Palliative Care (AREA)
- Pediatric Medicine (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/NL2016/050271 WO2017183956A1 (fr) | 2016-04-18 | 2016-04-18 | Acide linoléique et acide alpha-linolénique destinés à être utilisés pour réduire le déclin cognitif induit par un stress de vie précoce |
| NLPCT/NL2016/050271 | 2016-04-18 | ||
| EP16188154.5 | 2016-09-09 | ||
| EP16188154 | 2016-09-09 | ||
| PCT/NL2017/050246 WO2017183970A1 (fr) | 2016-04-18 | 2017-04-18 | Acide linoléique et acide alpha-linolénique pour utilisation pour réduire les déclin cognitif/réduction de la neurogenèse induit par le stress de vie précoce |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112018071493A2 true BR112018071493A2 (pt) | 2019-02-19 |
Family
ID=58639027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018071493-3A BR112018071493A2 (pt) | 2016-04-18 | 2017-04-18 | usos de ácido linoleico (la) e ácido alfa-linolênico (ala) na fabricação de uma composição nutricional, composição nutricional, método para prevenir declínio no funcionamento cognitivo induzido e método para prevenir redução na neurogênese induzida por estresse precoce |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3445353A1 (fr) |
| CN (1) | CN109310662A (fr) |
| BR (1) | BR112018071493A2 (fr) |
| RU (1) | RU2741495C2 (fr) |
| WO (1) | WO2017183970A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024121222A1 (fr) * | 2022-12-06 | 2024-06-13 | N.V. Nutricia | Formule pour nourrisson destinée à améliorer le développement cognitif |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596302B2 (en) * | 2000-04-13 | 2003-07-22 | Abbott Laboratories | Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
| WO2005000040A1 (fr) * | 2003-06-24 | 2005-01-06 | University Of Kansas Medical Center | Formule pour bebes |
| AU2006327996B2 (en) * | 2005-12-23 | 2012-03-29 | N.V. Nutricia | Infant nutritional compositions for preventing obesity |
| ATE509624T1 (de) * | 2005-12-23 | 2011-06-15 | Nutricia Nv | Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz |
| WO2009002145A1 (fr) * | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Composition lipidique destinée à améliorer l'activité cérébrale |
| AU2008269728B2 (en) * | 2007-06-26 | 2013-10-31 | N.V. Nutricia | Improving memory in subjects with mini-mental state examination of 24-26 |
| EP2346355B1 (fr) | 2008-09-02 | 2019-12-04 | N.V. Nutricia | Compositions nutritionnelles dotées de globules lipidiques de grande taille avec un enrobage de lipides polaires |
| EP2258216A1 (fr) * | 2009-06-02 | 2010-12-08 | Nestec S.A. | Composition nutritionnelle pour supporter le développement cérébral et fonction des tout-petits |
| CN101773223B (zh) * | 2010-02-11 | 2013-01-02 | 圣元营养食品有限公司 | 婴儿食品组合物 |
| WO2011115476A1 (fr) * | 2010-03-17 | 2011-09-22 | N.V. Nutricia | Nutrition du nourrisson destinée à améliorer la composition en acides gras des membranes cérébrales à un stade ultérieur de sa vie |
| JP6067558B2 (ja) * | 2011-06-29 | 2017-01-25 | 日本水産株式会社 | 恐怖記憶の軽減方法 |
| ES2725610T3 (es) * | 2013-12-12 | 2019-09-25 | Nestle Sa | Composiciones lácteas sintéticas que comprenden ácidos grasos poliinsaturados (PUFAS) para fomentar el establecimiento saludable de la función cognitiva en lactantes y niños varones y hembras |
-
2017
- 2017-04-18 BR BR112018071493-3A patent/BR112018071493A2/pt not_active Application Discontinuation
- 2017-04-18 CN CN201780037737.2A patent/CN109310662A/zh active Pending
- 2017-04-18 WO PCT/NL2017/050246 patent/WO2017183970A1/fr active Application Filing
- 2017-04-18 RU RU2018140486A patent/RU2741495C2/ru active
- 2017-04-18 EP EP17719941.1A patent/EP3445353A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017183970A1 (fr) | 2017-10-26 |
| CN109310662A (zh) | 2019-02-05 |
| RU2018140486A (ru) | 2020-05-19 |
| EP3445353A1 (fr) | 2019-02-27 |
| RU2018140486A3 (fr) | 2020-07-14 |
| RU2741495C2 (ru) | 2021-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2021003036A2 (es) | Compuestos de anillo fusionado | |
| ECSP17043316A (es) | Polvo de coleópteros | |
| BR112018015097A2 (pt) | composição e reatores | |
| BR112017018368A2 (pt) | composições contendo rna para o tratamento de doenças tumorais | |
| CL2017000201A1 (es) | Composiciones y métodos de uso para tratar trastornos metabólicos | |
| DOP2017000097A (es) | Composiciones y métodos de uso para tratar trastornos metabólicos | |
| ECSP17043318A (es) | Composición que contiene quitina y proteínas digeribles | |
| CL2020000632A1 (es) | Composición y método para el tratamiento del autismo. | |
| BR112018003745A2 (pt) | composições que compreendem um composto de urolitina | |
| BR112021025676A2 (pt) | Composições e métodos para tratar uma afecção mediada por th2 com o uso de prevotella | |
| BR112017025339A2 (pt) | composições nutricionais contendo um nível elevado de inositol e usos das mesmas | |
| CL2019001658A1 (es) | Derivados de la pirimidin enona tricíclica para la inhibición de rory y otros usos. | |
| UY36224A (es) | Compuestos tricíclicos de imidazo-pirimidinona | |
| BR112017003346A2 (pt) | derivados de pirazolopiridina, seus usos, e composição farmacêutica | |
| BR112017012714A2 (pt) | composição de liberação modificada, método para tratamento ou prevenção de uma doença ou condição, e, método cosmético para reduzir peso corporal. | |
| BR112018003780A2 (pt) | composições que compreendem um composto de urolitina | |
| BR112018007958A2 (pt) | composições e métodos que usam um polifenol para a saúde musculoesquelética | |
| BR112017007375A2 (pt) | composição compreendendo oligossa¬carídeos fut2 dependentes e lacto-n-neotetraose para uso na promoção do desenvolvimento e da cognição cerebral | |
| BR112018009941A8 (pt) | composição reguladora de crescimento vegetal com efeito sinergético | |
| BR112016025876A8 (pt) | composição, processos para preparar uma microcápsula e uma forma de dosagem unitária, forma de dosagem unitária, microcápsula, produto, uso de uma composição, e, método para tratar uma condição associada à vitamina k1 ou k2 | |
| BR112018000236A2 (pt) | composições nutricionais e métodos para a promoção do desenvolvimento cognitivo | |
| BR112018014590A2 (pt) | formulações/composições compreendendo um inibidor de btk | |
| BR112017006416A2 (pt) | composição nutricional para meio gastrointestinal para proporcionar perfil aperfeiçoado de microbioma e metabólico | |
| BR112019001919A2 (pt) | composição de tratamento de superfícies rígidas, método para fornecer o brilho da superfície e utilização da composição | |
| BR102015012091A8 (pt) | método para a preparação de uma solução de albumina humana, e, composição |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |